Charles River Laboratories International CRL
NYSE CRL
$296.78 +1.68 (+0.57%)
As of: Aug 27, 2026 · 3:59 PM EDT

Charles River Laboratories International (CRL) Income from Non-Controlling Interests (2009 - 2026)

Charles River Laboratories International (CRL) posted quarterly Income from Non-Controlling Interests of $265000.0 for Q4 2025, down 64.57% year-over-year from $748000.0 in Q4 2024, and down 76.63% quarter-over-quarter from $1.1 million in Q3 2025.

Charles River Laboratories International (CRL) Income from Non-Controlling Interests (2009 - 2026) Analysis & Trends

Charles River Laboratories International's Income from Non-Controlling Interests history runs 17 years deep, the most recent figure standing at $265000.0 for Q4 2025.

  • In Q4 2025, Income from Non-Controlling Interests fell 64.57% year-over-year to $265000.0; the TTM figure through Dec 2025 stood at $2.2 million (down 29.57% YoY), while the FY2025 annual figure was $2.2 million, down 29.57% from the prior year.
  • Income from Non-Controlling Interests for Q4 2025 stood at $265000.0, down from $1.1 million in the prior quarter.
  • The five-year high for Income from Non-Controlling Interests was $2.4 million in Q3 2023, with the low at $180000.0 in Q2 2024.
  • The 5-year median for Income from Non-Controlling Interests is $1.2 million (2022), against an average of $1.3 million.
  • The sharpest annual moves came in 2021 and 2024: Income from Non-Controlling Interests soared 3436.76% in 2021, then slumped 92.57% in 2024.
  • Charles River Laboratories International's Income from Non-Controlling Interests stood at $2.2 million in 2021, then decreased by 24.59% to $1.7 million in 2022, then rose by 10.14% to $1.9 million in 2023, then plunged by 59.96% to $748000.0 in 2024, then sank by 64.57% to $265000.0 in 2025.
  • Business Quant data shows CRL's Income from Non-Controlling Interests at $265000.0 in Q4 2025, $1.1 million in Q3 2025, and $367000.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Thermo Fisher Scientific 234.15 Bn 230.09 Bn 8.34 Bn 5.00 Mn
2 Danaher 152.10 Bn 147.75 Bn 3.61 Bn -
3 Natera 48.48 Bn 47.38 Bn 486.15 Mn -
4 Agilent Technologies 44.35 Bn 42.55 Bn 990.00 Mn -
5 Iqvia Holdings 43.68 Bn 41.60 Bn 1.44 Bn 2.00 Mn
6 Idexx Laboratories 43.02 Bn 42.83 Bn 779.09 Mn -
7 Illumina 34.39 Bn 33.22 Bn 770.00 Mn -
8 Mettler Toledo International 28.29 Bn 28.24 Bn 650.22 Mn -
9 Labcorp Holdings 27.51 Bn 27.37 Bn 1.11 Bn 400,000.00
10 Charles River Laboratories International 14.28 Bn 14.09 Bn 452.07 Mn 722,000.00

Historic Data

Download Data
DateValue
Jun 27, 2026 722,000.00
Dec 27, 2025 265,000.00
Sep 27, 2025 1.13 Mn
Jun 28, 2025 367,000.00
Mar 29, 2025 409,000.00
Dec 28, 2024 748,000.00
Sep 28, 2024 638,000.00
Jun 29, 2024 180,000.00
Mar 30, 2024 1.52 Mn
Dec 30, 2023 1.87 Mn
Sep 30, 2023 632,000.00
Jul 1, 2023 2.42 Mn
Apr 1, 2023 823,000.00
Dec 31, 2022 1.70 Mn
Sep 24, 2022 1.14 Mn
Jun 25, 2022 1.34 Mn
Mar 26, 2022 2.20 Mn
Dec 25, 2021 2.25 Mn
Sep 25, 2021 1.73 Mn
Jun 26, 2021 1.47 Mn